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Abstract
Introduction The aim of this study was to estimate excess costs of depression in Germany and to examine the influence of 
sociodemographic and socioeconomic determinants.
Methods Annual excess costs of depression per patient were estimated for the year 2019 by comparing survey data of 
individuals with and without self-reported medically diagnosed depression, representative for the German population aged 
18–79 years. Differences between individuals with depression (n = 223) and without depression (n = 4540) were adjusted 
using entropy balancing. Excess costs were estimated using generalized linear model regression with a gamma distribution 
and log-link function. We estimated direct (inpatient, outpatient, medication) and indirect (sick leave, early retirement) 
excess costs. Subgroup analyses by social determinants were conducted for sex, age, socioeconomic status, first-generation 
or second-generation migrants, partnership, and social support.
Results Total annual excess costs of depression amounted to €5047 (95% confidence interval [CI] 3214–6880) per patient. 
Indirect excess costs amounted to €2835 (1566–4103) and were higher than direct excess costs (€2212 [1083–3341]). Out-
patient (€498), inpatient (€1345), early retirement (€1686), and sick leave (€1149) excess costs were statistically significant, 
while medication (€370) excess costs were not. Regarding social determinants, total excess costs were highest in the younger 
age groups (€7955 for 18–29-year-olds, €9560 for 30–44-year-olds), whereas total excess costs were lowest for the oldest 
age group (€2168 for 65+) and first-generation or second-generation migrants (€1820).
Conclusions Depression was associated with high excess costs that varied by social determinants. Considerable differences 
between the socioeconomic and sociodemographic subgroups need further clarification as they point to specific treatment 
barriers as well as varying treatment needs.
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1 Introduction
Depressive disorders account for the third-highest number 
of years lived with disability (YLD) worldwide and for 7.5% 
of the total disease burden (YLD) in Germany [1, 2]. The 
12-month prevalence of depression in Germany was esti-
mated to be 9.9% in females and 4.2% in males, and for self-
reported medically diagnosed depression, it was estimated 
to be 8.1% and 3.8%, respectively [3]. Findings from two 
population-based surveys in Germany showed that the preva-
lence of depression did not change over time, but mental 
health outcomes (e.g., days with reduced activity) worsened, 
indicating that the burden of depression increased for the 
individual as well as society [4].
In this study, we matched a control group of individuals 
without depression to a group of individuals with depression 
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Key Points for Decision Makers 
The excess costs of individuals with depression vs. 
individuals without depression were 2.0-times higher for 
direct and 2.2-times higher for indirect excess costs.
A high share of excess costs accounted for by early 
retirement indicates that depression has severe conse-
quences, not only in the short term in terms of the num-
ber of days spent on sick leave, but also in the long term 
in the form of permanent productivity losses.
Depending on the subgroup considered, different pat-
terns emerge. As for age, the excess costs of depression 
were highest among young people (aged 18–29 years), 
and decreased with increasing age.
extent to which sociodemographic determinants influence 
the excess costs of depression. Previous COI studies of 
depression reporting excess costs have investigated the influ-
ence of sociodemographic determinants on overall health 
care costs without distinguishing between individuals with 
depression and individuals without depression.
Our primary objective was to estimate the direct and indi-
rect excess costs of depression for adults in Germany using 
data from the German Health Interview and Examination 
Survey for Adults (Studie zur Gesundheit Erwachsener in 
Deutschland, DEGS). The second objective was to investi-
gate whether the association between age and excess costs 
of depression that was found in the meta-analysis could be 
replicated. This study further extends current knowledge 
of the excess costs of depression in Germany, in particular 
for indirect costs, by using data that are representative of 
the German population aged 18–79 years. With this, pol-
icy makers will get a more precise estimate about the costs 
attributable to depression for Germany. Reporting excess 
costs by cost categories could identify resource-intensive 
health care services used by individuals with depression, 
information that can be taken into account when developing 
innovative care approaches (such as shifting inpatient care 
to outpatient care). The detailed results can provide useful 
information for future health economic modeling studies. 
Furthermore, a particular strength of using survey data lies 
in the possibility to analyze sociodemographic determinants, 
which are often only present in a rudimentary form in other 
data sources such as claims data. The excess costs by social 
subgroups can provide information on different patterns 
in the utilization of health care services and productivity 
losses, or potential barriers in the access to care.
We hypothesized that (1) direct and indirect costs are 
higher in individuals with depression than in individu-
als without depression, (2) excess costs are highest in the 
younger age groups and decrease with age, and (3) the 
excess costs of depression depend on sociodemographic 
and socioeconomic factors, including age, sex, partnership, 
social support, socioeconomic status (SES), and first-gen-
eration or second-generation migrants.
2  Methods
2.1  Study Design
The DEGS is part of the health monitoring conducted by 
the Robert Koch Institute. The design and method of the 
DEGS have been described elsewhere [18, 19]. The DEGS 
was conducted from 2008 to 2011 and included interviews, 
examinations, and tests [20]. Self-administered question-
naires were distributed to participants to obtain information 
on the physical, psychological, and social aspects of their 
and calculated the difference in mean costs between the 
group of individuals with depression and the control group 
(excess costs) to estimate the effect of depression on direct 
and indirect costs, i.e., the average treatment effect on the 
treated. The findings from a meta-analysis on cost-of-illness 
(COI) studies of depression showed that research has widely 
studied the cost of depression, but the proportion of studies 
reporting excess costs was comparatively small [5]. In the 
meta-analysis, the ratio of means (RoM) was utilized as an 
effect measure for the individual study results. The RoM is 
defined as the relative difference in costs between individu-
als with depression and individuals without depression [6, 
7]. The pooled RoM of direct costs in adults was 2.58 (95% 
confidence interval [CI] 2.01–3.31), meaning that costs were 
158% higher in individuals with depression than in the con-
trol group [5, 8]. The pooled RoM of indirect costs in adults 
was 2.28 (95% CI 1.75–2.98). The meta-analysis revealed an 
age effect: the relative difference in direct excess costs was 
highest among adolescent participants and decreased with 
age, being lowest among oldest (≥ 60 years) participants. 
The studies on the excess costs of depression that originated 
in Germany focused on particular subgroups (i.e., older age 
groups [9–11], anthroposophic care recipients [12], or the 
members of a specific health insurance fund [13]). Over-
all, evidence on the excess costs of depression from a soci-
etal perspective (i.e., including indirect excess costs) was 
sparse. Only one German study [12] assessed indirect costs, 
although depression is well known to be associated with 
productivity losses [14–16].
Although there are sociodemographic inequalities in 
the prevalence of depression [17], little is known about the 
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health. Information related to the patient’s medical history 
was obtained by physicians during computer-assisted per-
sonal interviews (CAPIs) [18–20]. In total, 8151 people 
participated in the DEGS, permitting representative cross-
sectional analysis for people aged 18–79 years [19].
2.2  Study Sample
The DEGS collected data on diagnosed depression and 
depressive symptoms. Diagnosed depression was measured 
as self-reported medically diagnosed depression in the 12 
months prior to the interview. In a CAPI, study participants 
were asked “Have you ever been diagnosed with depression 
by a physician or a psychotherapist?” (lifetime); if approved, 
this was followed by the question “Was the depression pre-
sent during the last 12 months?” Depressive symptoms dur-
ing the preceding 2 weeks were measured using the Ger-
man version of the Patient Health Questionnaire 9 (PHQ-9), 
wherein a score of ≥ 10 indicates at least moderate depres-
sive symptoms [21, 22].
As the individuals with depression needed to be com-
posed exclusively of participants with a confirmed diagnosis 
of depression, only participants with self-reported diagnosed 
depression were included. Previous studies have shown that 
costs were also higher when depression was assessed with 
the PHQ-9 [23–25]. To reduce the risk of including depres-
sion-related costs (e.g., as a result of undiagnosed depression 
or underreporting) in the control group, we did not include 
participants with self-reported diagnosed depression or cur-
rent depressive symptoms (i.e., with a PHQ-9 score of ≥ 10). 
Further, the study sample was restricted to participants with-
out missing values (complete data analysis).
2.3  Cost Assessment
We used DEGS data on service utilization and productiv-
ity losses to value these outcomes monetarily using aver-
age unit costs to estimate annual direct and indirect costs. 
The recall period on self-reported health service utilization 
was the 12 months prior to the interview with the exception 
of medication use (7 days) and any outpatient or inpatient 
medical rehabilitation (36 months). We estimated weekly 
medication costs and extrapolated them to annual costs. For 
medical rehabilitation, only the calendar year preceding the 
examination year was considered. Thus, the survey period 
only overlapped with the survey periods of the other vari-
ables, but it ensured that the frequency with which medical 
rehabilitations were considered actually corresponded to 
12 months. As no information was provided regarding the 
duration of medical rehabilitation, we assumed the mean 
duration of 30 days reported for Germany [26]. A detailed 
description of the methodology and the findings in relation 
to utilization of services can be found elsewhere [27]. After 
costs were allocated to all services, the individual items were 
summed to provide total costs, which in turn were reported 
separately in terms of direct and indirect costs. Direct costs 
were divided into outpatient, inpatient, and medication costs. 
Outpatient and inpatient costs were further divided into vari-
ous service providers. For indirect costs, a distinction was 
made between early retirement and sick leave.
Direct costs were assessed by valuing self-reported health 
service utilization monetarily. We valued 79% of costs using 
standardized unit costs for Germany [28] and medication 
costs using published medication prices from the German 
drug catalogue “Rote Liste” [29]. If unit costs were not avail-
able, we used data from an internal database of our institute 
(unpublished material) or the arithmetic mean of all other 
unit costs within the same cost category (e.g., mean over all 
outpatient physician specialization, if unit cost for a spe-
cific specialization was missed). More details on the unit 
costs can be found in the Electronic Supplementary Material 
(see S1 and S2). Indirect costs were assessed as productiv-
ity losses using the human capital approach. Productivity 
losses were valued monetarily using the average gross hourly 
wage in 2011 for full-time and part-time employees plus 
the employer’s contribution to social insurance [30, 31]. 
The costs of sick leave were calculated based on the self-
reported number of days spent on sick leave and weekly 
working hours. We estimated costs of early retirement if the 
study participants stated that they were retired for health 
reasons. We assumed the average daily working time of full-
time and part-time employees as productivity losses [31], 
which we valued with the average wage rates [30, 31]. If the 
study participants indicated that they were still employed, 
we subtracted the reported working hours from the assumed 
productivity losses. The duration of the retirement was 
unknown, so we have conservatively assumed 105.9 days 
(half a year without average days off due to holidays or sick 
leave) of lost productivity to estimate annual costs of early 
retirement. We accounted for inflation using consumer prices 
and reported the adjusted costs in 2019 euros [32].
2.4  Subgroup Analyses
We additionally estimated excess costs for social subgroups, 
which we selected based on previous findings on the utiliza-
tion of various medical services in Germany. Thus, in addi-
tion to sociodemographic subgroups such as age and gender, 
socioeconomic subgroups such as education and income, 
first-generation or second-generation migrants, and indica-
tors of social ties such as a partner/spouse or a high level of 
social support were analyzed [27, 33–39]. The influence of 
age on excess costs of depression was investigated by divid-
ing the sample into four age groups (18–29, 30–44, 45–64, 
and 65 years and older). SES was calculated as proposed by 
Lampert and colleagues, which enabled classification into 
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low-, medium-, or high-SES groups [40]. Individuals were 
considered first-generation or second-generation migrants if 
either the respondent or a parent was born abroad [37, 41]. 
People living in married or consensual unions were distin-
guished from those not currently in a relationship (with vs. 
without a partner). Social support was measured by dividing 
the 3-Item Oslo Social Support Scale sum score into two 
categories (low [< 9] and moderate/high [≥ 9]) [42].
2.5  Statistical Methods
After the selection of the control group, we adjusted the 
groups for potential covariates to reduce the risk of con-
founding in a non-randomized sample. We used entropy bal-
ancing (EB) for the group adjustment, as this reweighting 
method achieves better covariate balance than other common 
preprocessing methods such as propensity score matching 
[43]. EB directly assigns a weight to each observation in 
the control group that matches the treatment group, with 
minimum deviation from the initial value [43]. After EB, 
we calculated mean annual costs and corresponding standard 
errors for all cost categories for both groups, and estimated 
excess costs of depression using a generalized linear model 
(GLM) with gamma distribution and a log link [44]. All 
analyses were weighted using the weights obtained from 
EB. Thus, no other explanatory variables besides the diag-
nosis of depression were included in the GLM regression. 
For the subgroup analyses, EB and the estimation of excess 
costs were conducted separately for each characteristic of 
the social subgroups. Statistical significance was defined 
as p < 0.05. All statistical analyses were conducted using 
Stata (version 15). EB was conducted using the Stata pack-
age “ebalance” [45].
2.5.1  Covariates
We selected social and clinical covariates to adjust the dif-
ferences in the mean and variance between individuals with 
depression and the control group. First we selected 45 covar-
iates, of which some were excluded to avoid losing more 
than 15 % of the observations in the groups due to missing 
values. In the final model, the socio-demographic covari-
ates balanced for were age, sex, education, income, marital 
status, community size (rural, small-, mid-sized-, and large 
town), region (seven Nielsen areas), and physicians’ den-
sity (physicians per 100,000 inhabitants, categorized into 
four categories). Clinical covariates concerning health sta-
tus and risk factors were recognized disability (self-reported 
official recognition by the pension office [18]), body mass 
index, contraceptive pill use, use of hearing aid, physical 
activity (sport hours per week [46]), smoker status (current 
smoker—even if only occasionally [47]), and use of vision 
aid (glasses/contact lenses). Furthermore, we balanced for 
the following comorbidities: chronic inflammatory bowel 
disease, gastroduodenal ulcer, injury/poisoning, and joint 
pain (12-month prevalence), as well as arthrosis/degen-
erative joint disease, bronchial asthma, cancer, diabetes, 
epilepsy, hepatic cirrhosis, hepatitis, hypertension, kidney 
failure, migraine, prostatic hyperplasia, rheumatoid arthritis, 
and thyroid disease (lifetime prevalence), and not specified 
further diseases (current impairment/treatment). Table 1 pro-
vides more details on the included covariates.
Since the number of observations was smaller within the 
subgroups, we reduced the balancing model by excluding 
all covariates without statistically significant differences 
between the groups: education, region, hearing aid, physi-
cal activity, bronchial asthma, hepatitis, hepatic cirrhosis, 
injury/poisoning, kidney failure, prostatic hyperplasia, and 
rheumatoid arthritis. In addition, the social subgroup that 
was analyzed was excluded from the related reweighting 
scheme.
2.5.2  Sensitivity Analyses
We conducted several sensitivity analyses to test the robust-
ness of our results in relation to the assessment of produc-
tivity loss, the balancing scheme, and the selection of the 
depression identifier. There are several ways to evaluate pro-
ductivity loss. Therefore, we tested whether using specific 
wage rates with respect to employment status and sociode-
mographic characteristics instead of average wages would 
change the results in relation to indirect excess costs. Sec-
ond, we calculated unadjusted excess costs to test the influ-
ence of the adjustment on the results. Third, we used both 
adjusted and unadjusted analyses to test whether the results 
differed if the individuals with depression comprised those 
participants with an acute episode of depression, i.e., at least 
moderate current depressive symptoms based on the PHQ-9.
3  Results
3.1  Sample Characteristics
The final study sample consisted of 223 individuals with 
depression and 4540 individuals without depression. Some 
observations had to be excluded from the analysis for vari-
ous reasons, including missing data in relation to costs, 
depression status, or sociodemographic or clinical variables, 
and the need to exclude participants with depressive symp-
toms from the control group (see Table S3 in the Electronic 
Supplementary Material). As shown in Table 1, the sample 
characteristics of all predefined covariates were balanced 
between individuals with depression and individuals with-
out depression using EB. After EB, the average age of the 
participants was 52 years and 68.2% of the individuals with 
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Table 1  Pre- and post-weighting results using entropy balancing









Sociodemographic and socioeconomic covariates
 Age (mean) Mean 51.7 49.5 51.6
 Sex (% female) Male = 0, female = 1 68.2 48.9 68.0
 Education level (%) CASMIN classification
  Low 32.7 28.5 32.8
  Middle 50.7 50.9 50.6
  High 16.6 20.6 16.6
 Income (€) Mean (equivalent income) 1408.6 1558.6 1406.2
 Marital status (%)
  Married, living with partner 52.5 65.0 52.5
  Married, separated from partner 2.2 1.4 2.2
  Single 24.2 23.8 24.2
  Divorced 12.1 5.5 12.1
  Widowed 9.0 4.3 9.0
 Community size (%)
  Rural Inhabitants: < 5000 13.9 18.4 14.0
  Small town Inhabitants: 5000 to < 20,000 20.6 25.6 20.6
  Mid-sized town Inhabitants: 20,000 to < 100,000 27.4 29.1 27.3
  Large town Inhabitants: ≥ 100,000 38.1 26.9 38.1
 Region (%) Nielsen areas
  North-West 13.9 12.6 13.9
  North Rhine-Westphalia 18.8 18.5 18.8
  Central 16.1 12.1 16.1
  East (North) 16.1 17.4 16.1
  East (South) 10.8 14.4 10.8
  Bavaria 13.0 12.9 13.0
  Baden-Wuerttemberg 11.2 12.0 11.2
 Physician density (%) Physicians per 100,000 inhabitants
  Approximately 124 12.6 19.0 12.7
  Approximately 144 35.9 38.7 35.8
  Approximately 149 13.5 15.9 13.5
  Approximately 233 38.1 26.5 38.1
Clinical covariates
 Health status and risk factors
  Recognized disability (%) No = 0, yes = 1 29.2 12.1 29.1
  Body-mass-index (mean) kg/m2 28.0 26.7 27.9
  Contraceptive pill use (%) No = 0, yes = 1 56.5 38.5 56.4
  Hearing aid (%) No = 0, yes = 1 4.9 3.3 4.9
  Physical activity (%) 4 categories (sporting hours per week in the 
preceding 3 months)
63.2 69.8 63.2
  Smoker status (%) No = 0, yes = 1 (including occasional smok-
ers)
32.3 25.5 32.3
  Vision aid (%) No = 0, yes = 1 82.5 74.6 82.4
 Comorbidities
  Arthrosis/degenerative joint disease (%) No = 0, yes = 1 (lifetime prevalence) 34.1 20.1 34.0
  Bronchial asthma (%) No = 0, yes = 1 (lifetime prevalence) 9.9 7.4 9.9
  Cancer (%) No = 0, yes = 1 (lifetime prevalence) 10.3 6.3 10.3
  Chronic inflammatory bowel disease 
(%)
No = 0, yes = 1 (12-month prevalence) 3.1 0.3 3.1
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depression and 68.0% of those without depression were 
female.
3.2  Excess Costs
Total costs were estimated as €9539 in individuals with 
depression and €4492 in individuals without depres-
sion. Thus, excess costs amounted to €5047 (95% CI 
3214–6880). The share of direct and indirect excess 
costs was €2212 (95% CI 1083–3341) and €2835 (95% 
CI 1566–4103), respectively. All results were statistically 
significant. Regarding direct cost categories, the differ-
ences between the groups were statistically significant for 
both outpatient costs (€498 [95% CI 360–636]) and inpa-
tient costs (€1345 [95% CI 446–2244]). Medication excess 
costs (€370 [95% CI − 241–980]) were not statistically 
significant. The main contributor to outpatient excess costs 
was psychotherapist costs (€317), followed by psychiatrist/
neurologist costs (€103). Expressed as the relative differ-
ence in costs, psychotherapist and psychiatrist/neurologist 
costs were around 16- and 12-times higher, respectively, 
in individuals with depression than in individuals without 
depression. Inpatient excess costs were mainly caused by 
hospital visits (€1285). The indirect cost categories were 
statistically significant, with a higher share of indirect 
excess costs attributable to early retirement (€1686) than 
that attributable to sick leave (€1149). See Fig. 1, Table 2, 
and Supplementary Table S4 (see the Electronic Supple-
mentary Material) for detailed information. 
3.3  Social Subgroups
Across all determinants, total excess costs ranged from 
€1820 (for first-generation or second-generation migrants) 
to €9560 (for 30–44-year-olds). Direct excess costs ranged 
from €1174 (for first-generation or second-generation 
migrants) to €4819 (for 30–44-year-olds), and indirect 
excess costs ranged from €68 (for people aged 65 years 
and older) to €4741 (for 30–44-year-olds). The comparison 
of costs within each category (e.g., female) of the social 
subgroups provides information on which categories have 
significant excess costs. Total excess costs were statistically 
significant for females, all age groups except for those aged 
65+ years, individuals with and without partners, all SES 
groups, individuals with moderate/high social support, and 
individuals that were not first-generation or second-gener-
ation migrants. After dividing total excess costs into direct 
and indirect excess costs, the results were no longer statisti-
cally significant for the high SES group. In addition, indi-
rect excess costs were no longer statistically significant for 
people aged 18–20 years, without a partner or of low SES. 
More details are provided in the Electronic Supplementary 
Material, Table S5.
Conversely, a comparison between the categories of each 
subgroup revealed the extent to which the categories (e.g., 
females and males) differ with regard to excess costs, as indi-
cated by the RoM. Although the CIs for the social determi-
nants were wide and overlapped between subgroups, several 
tendencies can be seen (see Fig. 2a–c). However, caution 
CASMIN Comparative Analysis of Social Mobility in Industrial Nations
a N = 4540 observations in the control group were downweighted in order to match the group of individuals with depression
Table 1  (continued)









  Diabetes (%) No = 0, yes = 1 (lifetime prevalence) 13.0 6.8 13.0
  Epilepsy (%) No = 0, yes = 1 (lifetime prevalence) 3.1 1.0 3.1
  Gastroduodenal ulcer (%) No = 0, yes = 1 (12-month prevalence) 1.8 0.4 1.8
  Hepatic cirrhosis (%) No = 0, yes = 1 (lifetime prevalence) 0.9 0.2 0.9
  Hepatitis (%) No = 0, yes = 1 (lifetime prevalence) 6.7 5.8 6.7
  Hypertension (%) No = 0, yes = 1 (lifetime prevalence) 47.1 36.2 47.0
  Injury/poisoning (%) No = 0, yes = 1 (12-month prevalence) 10.8 10.4 10.8
  Joint pain (%) No = 0, yes = 1 (12-month prevalence) 77.6 53.5 77.5
  Kidney failure (%) No = 0, yes = 1 (lifetime prevalence) 2.2 1.5 2.2
  Migraine (%) No = 0, yes = 1 (lifetime prevalence) 23.3 10.1 23.3
  Prostatic hyperplasia (%) No = 0, yes = 1 (lifetime prevalence) 7.6 7.9 7.6
  Rheumatoid arthritis (%) No = 0, yes = 1 (lifetime prevalence) 4.5 2.3 4.5
  Thyroid disease (%) No = 0, yes = 1 (lifetime prevalence) 33.2 23.1 33.1
  Not specified other diseases (%) No = 0, yes = 1 (current impairment/treat-
ment)
53.8 38.0 53.7
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should be exercised when interpreting the results. Younger 
age was related to higher direct excess costs (RoM = 4.8 
for 18–29-year-olds and RoM = 4.7 for 30–44-year-olds), 
which declined with age (RoM = 1.6 for 45–64-year-olds 
and 65+-years-olds). This pattern also appeared in relation 
to indirect costs for the 18–29 (RoM = 6.1), 30–44 (RoM 
= 3.0), and 45–64 (RoM = 1.7) age groups. We also cal-
culated indirect excess costs for the 65+ age group (RoM 
= 3.7), although participants at that age tend not to work 
anymore, as can be seen from the low absolute indirect costs 
in individuals with depression (€94) and individuals without 
depression (€26). When considering excess costs by gender, 
females had higher excess costs than males. Not being in a 
relationship was correlated with higher direct excess costs, 
but lower indirect excess costs. The lack of a supportive 
social network was correlated with lower excess costs. The 
direct excess costs were higher for individuals with low SES 
than for individuals with medium or high SES, while the 
indirect excess costs were not. First-generation or second-
generation migrants incurred lower excess costs than for 
their peers.
3.4  Sensitivity Analyses
The results of the sensitivity analyses are shown in the Elec-
tronic Supplementary Material, Table S6. When productivity 
loss was assessed using specific wage rates, absolute indirect 
excess costs were slightly lower than in the main analysis 
(€2538 vs. €2835; RoM = 2.1 vs. RoM = 2.2). Contrary 
to the main analysis, unadjusted excess costs were in gen-
eral higher and more likely to be statistically significant. 
For example, the total excess costs of depression were 2.1-
times higher in the main analysis and 3.5-times higher in the 
unweighted analysis. When depression was assessed using 
the PHQ-9, the excess costs of individuals with an acute epi-
sode of depression (i.e., PHQ-9 ≥ 10) also increased relative 
to non-depressed individuals (RoM = 2.0). However, excess 
costs were generally lower than those of individuals with 
diagnosed depression, except for the direct cost categories 
outpatient clinics, general practitioner, other physicians, and 
outpatient medical rehabilitation.
4  Discussion
The purpose of this study was to calculate the direct and 
indirect excess costs of adults reporting a medical diagnosis 
of depression using DEGS data and to assess the impact of 
social determinants on excess costs.
The first hypothesis, that direct and indirect costs are 
higher in individuals with depression, was supported. Indi-
rect excess costs accounted for approximately 56% of total 
excess costs, indicating that the assessment of indirect costs 
is important from a societal perspective, as a reduction in 
the labor force directly affects the productivity of a country. 
In our analysis, the estimated RoM was 2.0 (1.5–2.6) for 
direct and 2.2 (1.7–3.0) for indirect excess costs, which was 
to some extent lower than that for the pooled results in the 
meta-analysis [5]. A possible explanation for the relatively 
small difference in costs between the groups might be that 
only unadjusted costs were pooled in the meta-analysis, 
while we conducted adjusted analyses. The findings of the 
Fig. 1  Estimated mean costs of 


























 H. König et al.
sensitivity analyses support this explanation, as the RoMs of 
the unadjusted excess costs were at or above the upper bound 
of the 95% CIs for the pooled RoM in the meta-analysis. 
Another reason might be that we used data from a popu-
lation survey, whereas the data used in the meta-analysis 
were obtained from various data sources and study samples. 
When our findings were compared with those of studies with 
a similar study design, the estimated results were within the 
expected range for direct costs (RoM = 1.04–4.81) and indi-
rect costs (RoM = 1.70–3.67) [48–55].
In our analysis, the individuals with depression were only 
those study participants with a self-reported diagnosis of 
depression. If depression was assessed using standard diag-
nostic instruments (such as PHQ-9, see sensitivity analyses), 
the use of health services was measured independently of a 
health professional’s depression diagnosis. Thus, a consider-
able share of them might be affected by an untreated depres-
sive disorder. Therefore, the sensitivity analyses also reflect 
the presence of unmet needs, resulting in a lower estimate 
of direct excess costs than that found in the main analysis.
In relation to the second hypothesis, the younger age 
groups incurred the highest overall excess costs. The RoM 
was highest at younger age and decreased with age. One 
possible explanation for this pattern could be that comorbidi-
ties increase with age, resulting in higher baseline costs [56, 
57]. For the groups of working age, increasing comorbidities 
might also be more likely to prompt early retirement, result-
ing in higher indirect baseline costs. As for sick leave, indi-
viduals with depression incurred lower costs with increasing 
age. However, the baseline costs of 18–29-year-olds were 
lower than for those in older age and peaked in the age group 
30–44 years, resulting in decreasing excess costs. Several 
studies that reported excess costs of depression showed that 
costs significantly increased with age [10, 48, 54, 58, 59], 
but none assessed how excess costs varied with age. We 
found one study that investigated the influence of age on the 
Table 2  Estimated mean annual excess costs of individuals with medically diagnosed depression (12-month prevalence) compared to individuals 
without medically diagnosed depression (in Euro, 2019)
Weighted covariates using entropy balancing: age, sex, education, income, marital status, community size, region, physicians density, recognized 
disability, body mass index, contraceptive pill use, use of hearing aids, physical activity, smoker status, use of vision aids, arthrosis/degenerative 
joint disease, bronchial asthma, cancer, chronic inflammatory bowel disease, diabetes, epilepsy, gastroduodenal ulcer, hepatic cirrhosis, hepatitis, 
hypertension, injury/poisoning, joint pain, kidney failure, migraine, prostate hyperplasia, rheumatoid arthritis, thyroid disease, and not specified 
other diseases
CI confidence interval, SE robust standard error
a N = 4540 observations in the control group were downweighted in order to match the group of individuals with depression
b Exponentiated coefficients and corresponding CIs
c Hospital emergency or outpatients department or a medical treatment center without overnight stays
Cost category Depression (n = 223) Control (n = 223)a Excess costs
Mean (SE) Mean (SE) Absolute difference [95% CI] P value Relative 
 differenceb 
[95% CI]
Total costs 9539 (890) 4492 (287) 5047 [3214–6880] < 0.001 2.1 [1.7–2.7]
Direct costs 4430 (557) 2218 (145) 2212 [1083–3341] < 0.001 2.0 [1.5–2.6]
 Outpatient costs 1050 (68) 552 (18) 498 [360–636] < 0.001 1.9 [1.6–2.2]
  Physicians 903 (61) 438 (13) 465 [342–588] < 0.001 2.1 [1.8–2.4]
   Psychiatrist/neurologist 112 (17) 10 (2) 103 [69–136] < 0.001 11.5 [7.5–7.7]
   Psychotherapist 338 (49) 21 (5) 317 [219–414] < 0.001 16.2 [9.4–7.9]
   General practitioner 112 (8) 83 (4) 30 [13–47] 0.001 1.4 [1.2–1.6]
   Other physicians 341 (21) 325 (11) 16 [− 31 to 63] 0.501 1.0 [0.9–1.2]
  Non-physicians 113 (18) 81 (7) 32 [− 6 to 70] 0.099 1.4 [1.0–2.0]
  Outpatient  clinicc 26 (9) 18 (3) 8 [− 10 to 27] 0.366 1.5 [0.7–3.0]
  Outpatient rehabilitation 7 (7) 15 (3) − 8 [− 23 to 7] 0.308 0.5 [0.1–3.5]
 Inpatient costs 2461 (443) 1116 (120) 1345 [446–2244] 0.003 2.2 [1.5–3.3]
  Hospital 2243 (438) 958 (113) 1285 [399–2172] 0.004 2.3 [1.5–3.7]
  Inpatient rehabilitation 217 (61) 158 (30) 59 [− 74 to 192] 0.381 1.4 [0.7–2.7]
 Medication costs 919 (306) 550 (59) 370 [− 241 to 980] 0.235 1.7 [0.8–3.3]
Indirect costs 5109 (618) 2274 (192) 2835 [1566–4103] < 0.001 2.2 [1.7–3.0]
 Early retirement 2596 (483) 911 (153) 1686 [694–2678] 0.001 2.9 [1.7–4.7]
 Sick leave 2512 (453) 1363 (129) 1149 [226–2072] 0.015 1.8 [1.2–2.7]
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Fig. 2  a Total excess costs 
by social subgroups (ratio of 
means). b Direct excess costs 
by social subgroups (ratio of 
means). c Indirect excess costs 
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excess costs of depression (18–64 vs. 65+), but the associa-
tion was not statistically significant [51]. Contrary to our 
findings, the difference in costs was almost equal for younger 
and older adults (RoM 2.00 vs. 1.95).
With regard to the third hypothesis, this study is one of 
the first to analyze the excess costs of depression based on 
social determinants. Some previous COI studies that have 
addressed the excess costs of depression have analyzed the 
influence of social determinants on costs [9–12, 48, 54, 58, 
60]. However, they all examined the influence of social 
determinants on overall health care costs, rather than excess 
costs, and so the results cannot be directly compared with 
our findings.
In our study, the estimated excess costs were higher 
among females than among males. This is in line with 
numerous findings [27, 35, 36, 39]. Previous studies on the 
use of psychiatric and psychotherapeutic services in Ger-
many have found that service uptake is higher among indi-
viduals with a low level of social support and without a 
steady partner, supporting the finding that these groups incur 
higher direct costs [35, 39]. However, the RoM of direct 
excess costs was lower for individuals with low social sup-
port, which needs further investigation. Contrary to this, 
individuals with low social support or without a steady 
partnership incurred relatively lower indirect excess costs 
than their peers. One reason could be that a partnership and 
a supportive network promotes a more responsible way of 
dealing with illness in relation to employment. As for SES, 
the direct costs of the control groups were lower for low 
SES than for the higher education levels. This supports the 
findings of studies showing that people with high SES tend 
to seek specialists in relation to outpatient care, whereas 
people with low SES tend to seek general practitioners [27, 
34]. For individuals with depression, direct costs decreased 
with higher SES status, resulting in decreasing excess costs. 
One reason for this might be that lower SES is associated 
with poorer mental well-being and a higher incidence of 
mental disorders [3, 61, 62]. Another reason might be that 
people with a higher education level seek out a more spe-
cific therapy, resulting in less health care utilization. Appar-
ently, further research is needed to investigate this relation. 
It is reasonable to suppose that indirect excess costs were 
higher with medium and high SES, as greater productiv-
ity losses can be expected in relation to people with higher 
SES. Previous analyses of the utilization of health services 
by members of migrant communities showed that in Ger-
many, even in relation to medical needs, first-generation or 
second-generation migrants tend to use services less fre-
quently than their peers [36, 38]. Possible reasons might 
be a lack of knowledge about existing health care services 
or barriers to the treatment (such as language or culture, a 
lack of intercultural education of persons in the health care 
sector or the fear of stigmatization) [37, 38, 63, 64]. Thus, 
with regard to excess costs, lower costs could be expected for 
first-generation or second-generation migrants, which was 
supported by our analyses.
4.1  Strengths and Limitations
This study analyzed the economic burden of depression 
in Germany using a representative sample of people aged 
18–79 years. Using data from a large population-based 
survey (DEGS) offers several advantages. Depression was 
assessed by clinically trained interviewers, providing high 
data quality as compared to analyses based on claims or self-
administered questionnaires. Especially in the case of mental 
disorders, data from patient surveys can cover more cost 
categories than claims or medical records [65]. Addition-
ally, DEGS contains measurements of depressive symptoms, 
which enables sensitivity analysis of individuals having an 
acute episode of depression. Participants with and without 
depression were contained in one dataset, and thus a sec-
ond data source with a potentially different framework was 
not needed to ‘create’ the control group. Since information 
on employment parameters was available, indirect costs as 
a result of productivity loss could be analyzed. Moreover, 
many patient characteristics were captured in the DEGS and 
could be used for the group adjustment. Treating the dif-
ferences between the groups using EB was an innovative 
approach that enabled numerous covariates to be adjusted 
simultaneously. Another strength of this study is that the 
influence of social determinants on costs was analyzed for 
both groups, enabling the identification of differences in 
excess costs between subgroups.
This study also has several limitations. DEGS was con-
ducted from 2008 to 2011. In ambulatory claims data, 
depression prevalence rose considerably in the last decade, 
especially in younger age groups [66]. Thus, estimated costs 
might have changed accordingly. However, in the absence of 
up-to-date comprehensive survey data, the presented estima-
tion relies on the most recent data for the general population. 
Further, the results might be biased, because information 
on utilization of health care services relied on participants’ 
self-reporting (recall bias and reporting bias). We adjusted 
for observed covariates in the depression and control groups 
using EB. Therefore, the results might be biased by unob-
servable variables and unadjusted covariates, like mental 
disorders other than depression. As for the subgroups, the 
differences in the excess costs might be to some extent influ-
enced by variations in the level of unmeasured confounding. 
Furthermore, numerous observations with missing values 
had to be excluded to facilitate a valid analysis, resulting 
in small sample sizes when investigating social subgroups. 
However, when comparing the analyzed sample of individu-
als with depression with the original sample in DEGS, the 
sample characteristics with respect to age (52 vs. 53 years), 
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sex (68.2% vs. 69.3% females), and average PHQ-9 score 
(9.1 vs. 9.4) remained stable. Self-reported depression 
diagnosis is a widely used measure of depression in health 
surveys, even though subject to bias. As validation by stand-
ardized depression diagnoses assessed in clinical interview 
indicates, only 51.8% of the individuals with self-reported 
diagnosis of depression met the Composite International 
Diagnostic Interview (CIDI) criteria of an affective disor-
der [67]. However, this can be qualified by the fact that there 
may still be a need for treatment, and that clinical interviews 
do not assess unspecific depression diagnoses, which are 
very common in health care [66].
Moreover, severely ill participants are underrepre-
sented in population surveys (e.g., because individuals 
with severe depression are less likely to participate due 
to their symptomatology and to be reached because they 
receive acute treatment in hospitals), increasing the risk of 
underestimation of costs. This study estimated costs from 
a societal perspective. However, important cost categories 
discussed in the literature, such as the costs of informal 
care, costs of supported accommodation, costs of crimi-
nal justice, or suicide-related costs, were not taken into 
account [68–70].
4.2  Implications
Indirect excess costs and inpatient excess costs had the high-
est share in total excess costs. Innovative care approaches 
such as integrated care or severity stepped therapy might 
help reduce hospital stays and days of sick leave, and also 
meet the needs of those affected. The subgroup analyses 
showed groups of individuals who receive many health care 
services, which might indicate a high need for care. In con-
trast, other subgroups showed comparatively lower excess 
costs, which could be an indication of existing barriers to 
care. For example, online interventions could be a helpful 
tool for individuals who are informed about existing care 
services, but do not use them due to fear of stigmatization. 
As for first-generation or second-generation migrants, there 
might be barriers to the treatment such as language, but also 
little intercultural education on the part of the health care 
providers.
5  Conclusion
In summary, depression is associated with high direct and 
indirect excess costs. Our analysis of social determinants 
showed that the excess costs of depression differed between 
subgroups, and identified potential barriers such as language 
or cultural barriers for first-generation or second-generation 
migrants to the use of health care services. Future COI 
studies should include a thorough adjustment for group 
differences to accurately identify disease-specific excess 
costs.
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